Role of Biochemical Markers in Early Detection and Prognostication of Cancer Pathology: A systemic Review

Abstract

The use of biochemical markers has revolutionized the field of oncology, offering invaluable tools 
for early cancer detection, monitoring treatment response, and predicting prognosis. This paper 
delves into the significance of various biochemical markers in cancer pathology, focusing on 
prostate-specific antigen (PSA), prostatic acid phosphatase (PAP), CA 125, carcinoembryonic 
antigen (CEA), alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG), CA 19-9, CA 15
3, CA 27-29, lactate dehydrogenase (LDH), and neuron-specific enolase (NSE).